Analyst Recommendations
41.87 -0.75(-1.75%)05/17/2024
Ultragenyx Pharmaceutical Inc. (RARE)
Ultragenyx Pharmaceutical Inc. (RARE)
2024: Total Recommendations Consensus
To Grade | # of Recommendations |
---|---|
Overweight | 7 |
Neutral | 4 |
Buy | 3 |
Outperform | 1 |
5 records were shown. To view all data, Upgrade to PRO plan with only $1
Upgrades & Downgrades